Combining BSO with L-PAM warrants clinical testing in advanced MM
10.1016/j.freeradbiomed.2021.06.005 28 CulletonB
Key resources include: ClinicalTrials.gov Search for new trials involving cagrilintide or retatrutide PubMed/MEDLINE Set alerts for publications on these compounds Major medical journals New England Journal of Medicine, The Lancet, JAMA for high-impact studies Endocrine Society conferences Annual meetings where phase 3 data is often first presented FDA briefing documents Detailed safety and efficacy data released during approval processes Understanding the broader landscape of peptide research helps contextualize developments with specific compounds
[ CrossRef ] [ Google scholar ] [ PubMed ] Meng S, Chanda P, Thandavarayan RA, Cooke JP
It stimulates insulin and suppresses glucagon, maintaining stable glucose levels even in individuals with insulin resistance or prediabetes
The older, less selective 1-adrenergic blocker prazosin is not a first-line choice for either high blood pressure or prostatic hyperplasia
